Strategic MRD Oncology Account Executive

Tempus AI; United States; À distance; USD 95 000 - 155 000; Plein temps

Résumé du poste

Tempus AI is seeking a MRD Clinical Account Executive to promote and sell MRD testing services to clinicians and providers across the North Houston territory.

You will build strategic plans, engage with C-suite stakeholders, and collaborate with Tempus teams to drive adoption in academic medical centers, health systems, and community practices. A successful track record in molecular diagnostics and revenue generation is required.

Qualifications

• Experience selling molecular diagnostics or MRD testing preferred.
• Proven ability to generate revenue in diagnostics or biotech.
• Direct account management with major cancer centers and health systems.
• Experience with oncology providers and GPOs is a plus.

Responsabilités

• Drive MRD testing service adoption across major U.S. cancer centers and health systems.
• Engage executives and key decision-makers to create opportunities.
• Develop strategic plans for client acquisition and retention with appropriate LSAs.
• Collaborate with Tempus sales teams to meet company goals.
• Identify partnerships between oncology clients and Tempus for MRD integration.
• Provide market feedback to leadership based on analysis.
• Implement a comprehensive territory business plan including budgets and travel.
• Represent Tempus with integrity and trust.

Connaissances

Consultative selling

Executive stakeholder engagement

Project management

Cross-functional collaboration

Strategic planning

Communication skills

Prioritization

Business acumen

Formation

B.S. in life science, biology, business, or marketing – MBA preferred

Outils

Salesforce.com

Excel

PowerPoint

Description du poste

Tempus AI is seeking a MRD Clinical Account Executive to promote and sell MRD testing services to clinicians and providers across the North Houston territory.

You will build strategic plans, engage with C-suite stakeholders, and collaborate with Tempus teams to drive adoption in academic medical centers, health systems, and community practices. A successful track record in molecular diagnostics and revenue generation is required.